Morphic Holding, Inc. (MORF)
NASDAQ: MORF · IEX Real-Time Price · USD
28.07
+0.09 (0.32%)
At close: Apr 26, 2024, 4:00 PM
27.52
-0.55 (-1.96%)
After-hours: Apr 26, 2024, 5:19 PM EDT
Morphic Holding Revenue
In the year 2023, Morphic Holding had annual revenue of $521.00K, a decrease of -99.26%.
Revenue (ttm)
$521.00K
Revenue Growth
-99.26%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
121
Market Cap
1.40B USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 521.00K | -70.29M | -99.26% |
| Dec 31, 2022 | 70.81M | 51.01M | 257.72% |
| Dec 31, 2021 | 19.79M | -25.15M | -55.96% |
| Dec 31, 2020 | 44.95M | 27.97M | 164.74% |
| Dec 31, 2019 | 16.98M | 13.62M | 405.57% |
| Dec 31, 2018 | 3.36M | - | - |
| Dec 31, 2017 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Agiliti | 1.17B |
| National HealthCare | 1.14B |
| Tilray Brands | 743.25M |
| InMode | 492.05M |
| ANI Pharmaceuticals | 486.82M |
| Veracyte | 361.05M |
| Arcus Biosciences | 117.00M |
| Gyre Therapeutics | 113.45M |
MORF News
- 3 days ago - Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024 - GlobeNewsWire
- 11 days ago - ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Morphic Holding, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 13 days ago - IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Morphic Holding, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 17 days ago - SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Morphic Holding, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 23 days ago - INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Morphic Holding, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 25 days ago - Ademi LLP Investigates Claims of Securities Fraud against Morphic Holding, Inc. - PRNewsWire
- 26 days ago - Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - Business Wire
- 5 weeks ago - Morphic Appoints Dr. Simon Cooper as Chief Medical Officer - GlobeNewsWire